News
A new study shows that oxytocin nasal spray helps mothers with postpartum depression interact more positively with their babies.
Researchers at Radboud University and the Radboudumc found that mothers with postpartum depression benefit from oxytocin ...
A psychedelic nasal spray requiring a much shorter period of clinical supervision has shown promise against ...
A mid-stage trial of BPL‑003 nasal spray shows promising results for treatment-resistant depression, igniting biotech ...
BPL-003 showed “robust” efficacy data in treatment-resistant depression, according to analysts from Jefferies, who noted that ...
A nasal spray for treatment-resistant depression has delivered strong clinical results and rekindled investor hopes.
2d
MyHighPlains on MSNBSA Behavioral Health now offering Spravato for adults with treatment-resistant depressionBSA Behavioral Health announced it is expanding its mental health services to include Spravato (esketamine) nasal spray, for ...
Research on synthetic psychedelics progresses, and there's hope to prove psilocybin safe and effective in intractable ...
10d
Clinical Trials Arena on MSNatai and Beckley Psytech’s psychedelic wins in Phase IIb depression trialThe companies are also running an open-label study to evaluate the long-term efficacy and safety of the psychedelic in ...
Often called the “love hormone” or the “cuddle hormone,” oxytocin promotes feelings of love, bonding, and well-being.
Amarillo Globe-News on MSN21h
Lone Star Lineman’s Rodeo winners advance to international competition in KansasThe rodeo drew hundreds of Xcel Energy employees and their family members, who gathered to cheer on teams and individual ...
Esketamine, a form of ketamine taken as a nasal spray, has been approved for the treatment for moderate to severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results